Press Releases (Page 74)
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ:ADMA) on behalf of ADMA Biologics stockholders. Our investigation concerns whether ADMA Biologics has violated the federal securities laws and/or engaged in other unlawful business practices. Click here... ❯❯❯
UNISYS ALERT: Bragar Eagel & Squire, P.C. is Investigating Unisys Corporation on Behalf of Unisys Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Unisys Corporation (“Unisys” or the “Company”) (NYSE: UIS) on behalf of Unisys stockholders. Our investigation concerns whether Unisys has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the... ❯❯❯
SUN COMMUNITIES ALERT: Bragar Eagel & Squire, P.C. is Investigating Sun Communities on Behalf of Sun Communities Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sun Communities (“Sun Communities” or the “Company”) (NYSE: SUI) on behalf of Sun Communities stockholders. Our investigation concerns whether Sun Communities has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to... ❯❯❯
MEDIAALPHA ALERT: Bragar Eagel & Squire, P.C. is Investigating MediaAlpha Inc. on Behalf of MediaAlpha Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against MediaAlpha Inc. (“MediaAlpha” or the “Company”) (NYSE: MAX) on behalf of MediaAlpha stockholders. Our investigation concerns whether MediaAlpha has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in... ❯❯❯
LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
LifeWallet’s Common Stock Will Begin Trading on Split-Adjusted Basis on Monday, November 18, 2024MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced that it will affect a reverse stock split of its Class A common stock at a reverse stock split... ❯❯❯
Mediation and Dispute Resolution for UK In-house Lawyers Training Course (ONLINE EVENT: June 9, 2025/ON-DEMAND)
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Mediation and Dispute Resolution for In-house Lawyers Training Course" training has been added to ResearchAndMarkets.com's offering. This webinar is a practical introduction to the complete process. It is presented by an experienced and active mediator and solicitor who will share her practical knowledge in an interactive way. There will be plenty of opportunities for questions and... ❯❯❯
Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44
HOUSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is honored to announce it was selected from a competitive field of numerous companies as one of the few U.S. bioscience cannabis companies invited to participate in the DEA hearings on the rescheduling of marijuana. Represented by CEO, Mr. Dante Picazo, CBIH will present clinical trial data showcasing the therapeutic benefits and... ❯❯❯
LifeWallet Announces New Comprehensive Settlements Totaling More Than $5.9 Million, Continued Progress in Recoveries on Owned Claims and Acquiring Rights to Additional Claims, and Initiatives to Eliminate Wasteful Medicare Spending by Launching Beta Testing of Its Clearinghouse Solution, Built in Partnership with Palantir Technologies, Inc.
MIAMI, Nov. 11, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet” or “the Company”) announces new comprehensive settlements totaling more than $5.9 million, continued progress in recoveries on owned claims and acquiring rights to additional claims, and advancing initiatives to eliminate wasteful spending of Medicare dollars and improve federal cost-cutting measures by reducing improper payments... ❯❯❯
MYNARIC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Mynaric AG and Encourages Investors to Contact the Firm
NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or the “Company”) (NASDAQ:MYNA) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Mynaric securities between June 20, 2024 and... ❯❯❯
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Metagenomi securities pursuant and/or... ❯❯❯